BIOMAT Database Logo BIOMAT Database Logo

Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents. 2023

Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Chemistry Department, Faculty of Science, Assiut University, Assiut 71516, Egypt; Chemistry Department, Faculty of Science, Taiz University, Taiz, Yemen.

In this study, new derivatives of the antitubercular and anti-inflammatory drug, 4-aminosaliclic acids (4-ASA) were synthesized, characterized, and evaluated for these activities. In vivo and in viro evaluation of anti-inflammatory activity revealed that compounds 10, 19 and 20 are the most active with potent cyclooxygenase-2 (COX-2) and 5-lipooxgenase (5-LOX) inhibition and without causing gasric lesions. The minimum inhibitory concentrations (MIC) of the newly synthesized compound were, also, measured against Mycobacterium tuberculosis H37RV. Among the tested compounds 17, 19 and 20 exhibited significant activities against the growth of M. tuberculosis. 20 is the most potent with (MIC 1.04 µM) 2.5 folds more potent than the parent drug 4-ASA. 20 displayed low cytotoxicity against normal cell providing a high therapeutic index. Important structure features were analyzed by docking and structure-activity relationship analysis to give better insights into the structural determinants for predicting the anti-inflammatory and anti-TB activities. Our results indicated that compounds 19 and 20 are potential lead compounds for the discovery of dual anti-inflammatory and anti-TB drug candidates.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010131 Aminosalicylic Acid An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid. 4-Aminosalicylic Acid,p-Aminosalicylic Acid,para-Aminosalicylic Acid,Alumino-4-Aminosalicylic Acid,Pamisyl,Rezipas,p-Aminosalicylic Acid Monolithium Salt,p-Aminosalicylic Acid Monopotassium Salt,p-Aminosalicylic Acid Monosodium Salt,p-Aminosalicylic Acid, Aluminum (2:1) Salt,p-Aminosalicylic Acid, Calcium (2:1) Salt,p-Aminosalicylic Acid, Monosodium Salt, Dihydrate,4 Aminosalicylic Acid,Acid, Aminosalicylic,Alumino 4 Aminosalicylic Acid,p Aminosalicylic Acid,p Aminosalicylic Acid Monolithium Salt,p Aminosalicylic Acid Monopotassium Salt,p Aminosalicylic Acid Monosodium Salt,para Aminosalicylic Acid
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
October 2014, Chemical biology & drug design,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents.
December 2023, RSC medicinal chemistry,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Molecular docking, synthesis and biological screening of mefenamic acid derivatives as anti-inflammatory agents.
April 2017, European journal of pharmacology,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents.
February 2017, Bioorganic & medicinal chemistry letters,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Synthesis, biological evaluation and molecular docking of quinazoline-4(1H)-one derivatives as anti-inflammatory and analgesic agents.
January 2011, Acta poloniae pharmaceutica,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Synthesis and Biological Evaluation of Some New Chalcone Derivatives as Anti-inflammatory Agents.
January 2023, Current drug discovery technologies,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Synthesis, biological evaluation and molecular docking studies of novel diosgenin derivatives as anti-inflammatory agents.
October 2022, Bioorganic chemistry,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDIES OF AROMATIC SULFONAMIDE DERIVATIVES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS.
September 2016, Acta poloniae pharmaceutica,
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Chromonyl-aminosalicylic acid derivatives as possible antimycobacterial agents.
December 1995, Farmaco (Societa chimica italiana : 1989),
Maha Q M Qahtan, and Etify A Bakhite, and Jyothi Kumari, and Ahmed M Sayed, and Mahmoud Kandeel, and Dharmarajan Sriram, and Hajjaj H M Abdu-Allah
Synthesis and biological evaluation of quinic acid derivatives as anti-inflammatory agents.
September 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!